2回の再発後, プリマキン増量投与によって寛解をみた三日熱マラリアの1例

書誌事項

タイトル別名
  • A Case of Vivax Malaria in which Remission was Achieved by Primaquine at 1.5 Times the Standard Dose After Two Earlier Relapses
  • その抗体価の推移を含めて

抄録

A 22-year-old male student, who had been to Indonesia, was admitted to our hospital because of a high grade fever on October 12, 1990. On admission, vivax malaria parasites were detected in his blood smears and the antibody titers against Plasmodium vivax and P. falciparum antigen were respectively 1: 1024 and 1: 64 by the indirect fluorescent antibody test. Therefore, he was diagnosed as having vivax malaria and was treated with sulfadoxine/pyrimethamine (Fansidar), followed by primaquine at 15mg/day for 14 days. However, relapse occurred twice after treatment with the above-mentioned standard dose of primaquine. After his second relapse, he was treated with primaquine at 22.5mg/day for 14 days and remission was finally achieved without any adverse reactions. The antibody titer against P. vivax did not re-increase during the first and second relapses.

収録刊行物

  • 感染症学雑誌

    感染症学雑誌 67 (4), 371-375, 1993

    一般社団法人 日本感染症学会

詳細情報 詳細情報について

  • CRID
    1390282680023792768
  • NII論文ID
    130004330097
  • DOI
    10.11150/kansenshogakuzasshi1970.67.371
  • ISSN
    1884569X
    03875911
  • PubMed
    8315306
  • データソース種別
    • JaLC
    • Crossref
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ